BioSpace News Archive

Research Supported by March of Dimes May Help Explain Common Pregnancy Complications

Christopher Heckman to focus on Oncology Center of Development as Dr. Art Wamil joins as lead neurologist

New emergency Oxygen technology is now available to provide Oxygen to the more than 7 million breathing emergencies that occur every year.

Combined offering integrates EHR network and proactive patient services to improve access and adherence [30-April-2019] LAS VEGAS , April 30, 2019 /PRNewswire/ -- EVERSANA ™, the leading independent provider of global services to the life science industry, and OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging platform focused on affordabili

Mayne Pharma Group Limited is pleased to announce that the US Food and Drug Administration has approved the trade name LEXETTE™ for the approved drug halobetasol propionate foam, 0.05%.

OncoCell MDx, a company developing novel noninvasive diagnostic and prognostic tests by harnessing the power of the immune system, today announced the appointment of Mark McDonough as its president, chief executive officer (CEO) and member of the Board of Directors. McDonough succeeds company co-founder, investor and Chairman/CEO Harry Stylli, Ph.D. Stylli continues as the executive chairman of the company.

New facility focuses on specialized drug discovery technologies and discovery research across gastrointestinal and neuroscience therapeutic areas

Humana® is the second major insurer to post a coverage policy for Pulmonx’s Zephyr Endobronchial Valve Treatment

The Quell Foundation remains committed to its mission to reduce the number of suicides, overdoses and, incarcerations of people with mental health illness. As a testament to achieving its mission, The Foundation is pleased to announce that it has distributed nearly $1.3 million to students across the country since its inception in 2016.

Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the second quarter and first six months ended March 31, 2019.